Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for smoking cessation in schizophrenia
NCT00644969Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of varenicline in nicotine dependence, sponsored by Pfizer. Started May 2008; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00644969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644969.